AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-5.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.74B
AUM Growth
-$558M
(-13%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
292
New
63
Increased
75
Reduced
60
Closed
70
Top Buys
| 1 |
Freshpet
FRPT
|
$59.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$54.6M |
| 3 |
Keurig Dr Pepper
KDP
|
$37.6M |
| 4 |
STAAR Surgical
STAA
|
$37.5M |
| 5 |
Smith & Nephew
SNN
|
$36.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.4M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$79.9M |
| 3 |
GSK
GSK
|
$77.5M |
| 4 |
AB InBev
BUD
|
$68M |
| 5 |
Humana
HUM
|
$67.7M |
Sector Composition
| 1 | Healthcare | 63.24% |
| 2 | Consumer Discretionary | 12.22% |
| 3 | Consumer Staples | 9.75% |
| 4 | Technology | 9.6% |
| 5 | Communication Services | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Levi Strauss
LEVI
$8.79B
| $3.43M | 0.05% |
220,000
-330,000
| -60% | -$5.14M |
|
127
Scilex Holding
SCLX
$159M
| $3.43M | 0.05% |
394,057
-116,725
| -23% | -$1.02M |
|
128
Spyre Therapeutics
SYRE
$1.03B
| $3.23M | 0.05% |
200,000
| – | – |
|
129
Amer Sports
AS
$20.3B
| $2.91M | 0.04% |
+108,994
| New | +$2.91M |
|
130
Spotify
SPOT
$146B
| $2.78M | 0.04% |
5,059
+276
| +6% | +$152K |
|
131
Rockwell Medical
RMTI
$55.8M
| $2.67M | 0.04% |
2,366,144
-677,534
| -22% | -$766K |
|
132
Capri Holdings
CPRI
$2.53B
| $2.66M | 0.04% |
135,000
-300,000
| -69% | -$5.92M |
|
133
FibroGen
FGEN
$48.9M
| $2.63M | 0.04% |
340,000
+68,000
| +25% | +$527K |
|
134
Intellia Therapeutics
NTLA
$1.29B
| $2.59M | 0.04% |
+364,000
| New | +$2.59M |
|
|
NB
135
NioCorp Developments
NB
$310M
| $2.57M | 0.04% |
+1,306,273
| New | +$2.57M |
|
136
Kartoon Studios
TOON
$38.5M
| $2.54M | 0.04% |
4,095,934
-466,066
| -10% | -$289K |
|
137
SuperCom
SPCB
$43.1M
| $2.42M | 0.04% |
+363,470
| New | +$2.42M |
|
138
Victoria's Secret
VSCO
$2.1B
| $2.23M | 0.03% |
+120,000
| New | +$2.23M |
|
139
Curis
CRIS
$21M
| $2.17M | 0.03% |
1,033,368
+957,368
| +1,260% | +$2.01M |
|
140
Mural Oncology
MURA
$35.9M
| $2.17M | 0.03% |
1,722,000
+22,000
| +1% | +$27.7K |
|
|
MKZR
141
MacKenzie Realty Capital, Inc. Common Stock
MKZR
$9.67M
| $2.17M | 0.03% |
+144,574
| New | +$2.17M |
|
|
SDST
142
Stardust Power Inc. Common Stock
SDST
$25.4M
| $2.13M | 0.03% |
+4,526,000
| New | +$2.13M |
|
143
Target
TGT
$42.3B
| $2.06M | 0.03% |
19,733
-35,790
| -64% | -$3.74M |
|
144
Zura Bio
ZURA
$143M
| $1.98M | 0.03% |
1,536,000
+36,000
| +2% | +$46.4K |
|
145
Calidi Biotherapeutics
CLDI
$8.56M
| $1.88M | 0.03% |
+276,833
| New | +$1.88M |
|
146
AstraZeneca
AZN
$253B
| $1.76M | 0.03% |
24,000
-76,000
| -76% | -$5.59M |
|
147
Enlivex Therapeutics
ENLV
$25.3M
| $1.73M | 0.03% |
1,781,931
-426,069
| -19% | -$413K |
|
148
Intensity Therapeutics
INTS
$13.3M
| $1.72M | 0.03% |
872,547
-254,321
| -23% | -$501K |
|
149
BJ's Restaurants
BJRI
$742M
| $1.71M | 0.03% |
50,000
-300,000
| -86% | -$10.3M |
|
150
ProMIS Neurosciences
PMN
$22.3M
| $1.62M | 0.02% |
2,334,826
-175,151
| -7% | -$122K |
|